Literature DB >> 19282108

An evaluation of the efficacy of compound alpha and triclabendazole against two isolates of Fasciola hepatica.

M McConville1, G P Brennan, A Flanagan, H W J Edgar, R E B Hanna, M McCoy, A W Gordon, R Castillo, A Hernández-Campos, I Fairweather.   

Abstract

Seventy indoor-reared sheep were divided into 10 groups to test the efficacy of the experimental fasciolicide, compound alpha (15mg/kg) against triclabendazole (TCBZ)-resistant and TCBZ-susceptible F. hepatica infections. Activity against the Sligo TCBZ-resistant isolate was tested at three time points post-infection (p.i.): 3 days, 4 weeks and 12 weeks (Groups 1-3, respectively). A parallel trial was carried out using TCBZ (10mg/kg) (Groups 5-7): this provided a direct comparison between the efficacies of the two drugs. Group 4 served as an untreated Sligo control. Groups 8 and 9 were setup to test the efficacy of TCBZ and compound alpha against 12-week-old and 4-week-old TCBZ-susceptible, Cullompton infections, respectively. Group 10 served as an untreated Cullompton control. Sheep were sacrificed at 16 weeks p.i. and efficacies were determined. All remaining flukes were collected and measured, before being processed for whole-mount staining to assess the condition of their reproductive structures (testis, vitellaria, ovary and uterus). A second study was carried out to test the activity of compound alpha (15mg/kg) against mature 12-week-old TCBZ-susceptible F. hepatica infections in sheep. Eighteen sheep were divided into two groups, A and B. Group A was treated and Group B served as an untreated control group. Efficacy was determined by reduction in faecal egg counts. The results showed that, whilst compound alpha was very active against adult TCBZ-susceptible flukes, producing a 100% reduction in faecal egg counts, it only caused a 62.5% reduction in fluke burden against juvenile flukes. Moreover, compound alpha was not effective against any stage of infection with TCBZ-resistant F. hepatica in sheep. Data from the trial also revealed biological differences between the two isolates. Thus, Sligo flukes were smaller in size and produced fewer eggs than the Cullompton flukes and their cysts were less infective to sheep. However, they reached the bile ducts more quickly and their eggs appeared in the faeces >2 weeks earlier.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19282108     DOI: 10.1016/j.vetpar.2009.02.004

Source DB:  PubMed          Journal:  Vet Parasitol        ISSN: 0304-4017            Impact factor:   2.738


  16 in total

1.  Potentiation of triclabendazole sulphoxide-induced tegumental disruption by methimazole in a triclabendazole-resistant isolate of Fasciola hepatica.

Authors:  Catherine Devine; Gerard P Brennan; Carlos E Lanusse; Luis I Alvarez; Alan Trudgett; Elizabeth Hoey; Ian Fairweather
Journal:  Parasitol Res       Date:  2010-03-25       Impact factor: 2.289

2.  Surface changes in adult Fasciola hepatica following treatment in vivo with the experimental fasciolicide, compound alpha.

Authors:  M McConville; G P Brennan; A Flanagan; R E B Hanna; H W J Edgar; R Castillo; A Hernández-Campos; I Fairweather
Journal:  Parasitol Res       Date:  2009-05-21       Impact factor: 2.289

3.  Fasciola hepatica: disruption of spermatogenesis by the fasciolicide compound alpha.

Authors:  Maeve McConville; Robert E B Hanna; Gerard P Brennan; Maurice McCoy; Hillary W J Edgar; Shirley McConnell; Rafael Castillo; Alicia Hernández-Campos; Ian Fairweather
Journal:  Parasitol Res       Date:  2009-11-18       Impact factor: 2.289

4.  Efficacy of nitroxynil against Fasciola hepatica resistant to triclabendazole in a naturally infected sheep flock.

Authors:  Maria Martínez-Valladares; Maria del Rosario Famularo; Nelida Fernández-Pato; Luciano Castañón-Ordóñez; Coral Cordero-Pérez; Francisco Antonio Rojo-Vázquez
Journal:  Parasitol Res       Date:  2010-08-03       Impact factor: 2.289

Review 5.  Current status of food-borne trematode infections.

Authors:  R Toledo; J G Esteban; B Fried
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-01-08       Impact factor: 3.267

6.  Unchanged triclabendazole kinetics after co-administration with ivermectin and methimazole: failure of its therapeutic activity against triclabendazole-resistant liver flukes.

Authors:  Laura Ceballos; Laura Moreno; Luis Alvarez; Laura Shaw; Ian Fairweather; Carlos Lanusse
Journal:  BMC Vet Res       Date:  2010-02-03       Impact factor: 2.741

7.  RCB20, an experimental benzimidazole derivative, affects tubulin expression and induces gross anatomical changes in Taenia crassiceps cysticerci.

Authors:  Adrián Márquez-Navarro; América Pérez-Reyes; Armando Zepeda-Rodríguez; Olivia Reynoso-Ducoing; Alicia Hernández-Campos; Francisco Hernández-Luis; Rafael Castillo; Lilian Yépez-Mulia; Javier R Ambrosio
Journal:  Parasitol Res       Date:  2013-03-17       Impact factor: 2.289

8.  Effect of lipopolysaccharide (LPS) from Ochrobactrum intermedium on sheep experimentally infected with Fasciola hepatica.

Authors:  J M Martínez-Pérez; D Robles-Pérez; F Valcárcel-Sancho; A M González-Guirado; I Casanova-García de Castro; J M Nieto-Martínez; F A Rojo-Vázquez; M Martínez-Valladares
Journal:  Parasitol Res       Date:  2013-06-06       Impact factor: 2.289

9.  Efficiency comparison of experimental fosfatriclaben with three commercial fasciolicides in experimentally infected sheep.

Authors:  Rosa Arias-García; Yolanda Vera-Montenegro; Miguel Flores-Ramos; Rafael Castillo; Alicia Hernández-Campos; Froylán Ibarra-Velarde
Journal:  Parasitol Res       Date:  2020-06-09       Impact factor: 2.289

10.  Effects of Mirazid(®) and myrrh volatile oil on adult Fasciola gigantica under laboratory conditions.

Authors:  A M Massoud; H A Shalaby; R M El Khateeb; M S Mahmoud; M A Kutkat
Journal:  Asian Pac J Trop Biomed       Date:  2012-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.